Ignite Creation Date:
2024-05-06 @ 8:09 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06279065
Status:
RECRUITING
Last Update Posted:
2024-05-09
First Post:
2024-02-15
Brief Title:
Investigation of the Influence of the Human Microbiome on Giant Cell Arteritis
Sponsor:
University of Bonn
Organization:
University of Bonn
Study Overview
Official Title:
Investigation of the Influence of the Human Microbiome on the Pathogenesis and Recurrence Probability in Giant Cell Arteritis
Status:
RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
GCA-Biom
Brief Summary:
The longitudinal observational study aims to assess the impact of the microbiome especially the gut-microbiome in the emergence and course of giant cell arteritis abbr GCA patients At diagnosis and 6 month follow up we will analyze the oral blood and gut microbiome from GCA patients and healthy controls Thereby identified potential candidate biota will be further analyzed for possible interactions and influence on the immune system
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None